Obex

DIETARY_SUPPLEMENT4 trials

Sponsors

Catalysis SL, Catalysis, S.L. laboratory

Conditions

ObesityOverweightOverweight and Obesity

Phase 2

Obex, a Nutritional Supplement, in Overweight and Obese Spanish Women

CompletedNCT01934036

Catalysis SLObesity, Overweight

Start: 2013-08-31End: 2014-02-28Updated: 2014-02-25

Effects of Obex in Overweight and Obese Patients

CompletedNCT02145442

Catalysis SLObesity, Overweight

Start: 2014-06-30End: 2014-11-30Updated: 2018-05-08

Phase 3

Obex® - Overweight and Obese - Adults - Phase III

Active, not recruitingRPCEC00000267

Catalysis, S.L. laboratoryObesity

Start: 2018-05-02Target: 160Updated: 2026-08-10

Evaluation of Obex® in Overweight and Obesity

CompletedNCT03541005

Catalysis SLOverweight and Obesity

Start: 2018-10-01End: 2021-07-03Updated: 2021-10-21

Related Papers

Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial

BMC Complementary Medicine and Therapies2023-02-202 citations